Axon Enterprise, Inc $AXON Shares Purchased by Andra AP fonden

Andra AP fonden increased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 2,618.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 548,469 shares of the biotechnology company’s stock after buying an additional 528,293 shares during the period. Axon Enterprise accounts for 3.4% of Andra AP fonden’s portfolio, making the stock its 5th largest holding. Andra AP fonden owned 0.68% of Axon Enterprise worth $307,477,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. State Street Corp increased its position in shares of Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after purchasing an additional 209,879,882 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of Axon Enterprise by 8,432.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after acquiring an additional 3,496,493 shares in the last quarter. Nykredit A S bought a new stake in shares of Axon Enterprise during the second quarter worth $698,937,000. Norges Bank acquired a new stake in Axon Enterprise in the 4th quarter valued at about $515,764,000. Finally, Bank of America Corp DE acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $286,684,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares in the company, valued at $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the business’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 67,397 shares of company stock valued at $38,160,884 in the last 90 days. Insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON traded up $6.83 during mid-day trading on Tuesday, reaching $458.89. The company’s stock had a trading volume of 246,271 shares, compared to its average volume of 1,053,399. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $792.16. The business has a 50-day simple moving average of $545.60 and a two-hundred day simple moving average of $485.63. The stock has a market cap of $37.28 billion, a P/E ratio of 190.36, a PEG ratio of 8.43 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company’s quarterly revenue was up 35.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.12 earnings per share. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AXON has been the subject of several recent research reports. UBS Group boosted their price objective on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $715.00 target price on shares of Axon Enterprise in a research note on Thursday, August 6th. Morgan Stanley raised their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, September 2nd. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $721.57.

About Axon Enterprise

Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.

The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.